Related references
Note: Only part of the references are listed.How do pathogens drive the evolution of paired receptors?
Munir Akkaya et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
CD200R signaling in tumor tolerance and inflammation: A tricky balance
Tomasz F. Rygiel et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Chronic Infection Drives Expression of the Inhibitory Receptor CD200R, and Its Ligand CD200, by Mouse and Human CD4 T Cells
Stefano Caserta et al.
PLOS ONE (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Introduction to current and future protein therapeutics: A protein engineering perspective
Paul J. Carter
EXPERIMENTAL CELL RESEARCH (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
Xi Wen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Heterogeneity in the CD200R paired receptor family
Munir Akkaya et al.
IMMUNOGENETICS (2010)
Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents
Lei Jiang et al.
IMMUNOLOGY (2010)
Downstream of Tyrosine Kinase 1 and 2 Play Opposing Roles in CD200 Receptor Signaling
Robin Mihrshahi et al.
JOURNAL OF IMMUNOLOGY (2010)
CD200R surface expression as a marker of murine basophil activation
M. N. Torrero et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1)
Lei Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Inhibition and Activation by CD244 Depends on CD2 and Phospholipase C-γ1
Nicholas G. Clarkson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Essential Roles for Dok2 and RasGAP in CD200 Receptor-Mediated Regulation of Human Myeloid Cells
Robin Mihrshahi et al.
JOURNAL OF IMMUNOLOGY (2009)
Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade
Christian P. Pallasch et al.
LEUKEMIA RESEARCH (2009)
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
Jenna L. Cash et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage
Alan B. Cantor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A critical function for CD200 in lung immune homeostasis and the severity of influenza infection
Robert J. Snelgrove et al.
NATURE IMMUNOLOGY (2008)
Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression
Anke Kretz-Rommel et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-Independent manner
Toshiyuki Kojima et al.
JOURNAL OF IMMUNOLOGY (2007)
Eosinophils from lineage-ablated ΔdblGATA bone marrow progenitors:: The dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo
Kimberly D. Dyer et al.
JOURNAL OF IMMUNOLOGY (2007)
Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-α and mixed leukocyte culture responses by CD200
Ivo Boudakov et al.
TRANSPLANTATION (2007)
CD200 expression on tumor cells suppresses antitumor immunity: New approaches to cancer immunotherapy
Anke Kretz-Rommel et al.
JOURNAL OF IMMUNOLOGY (2007)
The SIRP family of receptors and immune regulation
AN Barclay et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines
DC Tomlinson et al.
CANCER RESEARCH (2005)
Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor
D Hatherley et al.
JOURNAL OF IMMUNOLOGY (2005)
The CD200 receptor is a novel and potent regulator of murine and human mast cell function
HM Cherwinski et al.
JOURNAL OF IMMUNOLOGY (2005)
Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family
G Brooke et al.
JOURNAL OF IMMUNOLOGY (2004)
CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells
D Voehringer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular mechanisms of CD200 inhibition of mast cell activation
SL Zhang et al.
JOURNAL OF IMMUNOLOGY (2004)
CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules
R Gorczynski et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of the CD200 receptor family in mice and humans and their interactions with CD200
GJ Wright et al.
JOURNAL OF IMMUNOLOGY (2003)
Anti-CD200R ameliorates collagen-induced arthritis in mice
RM Gorczynski et al.
CLINICAL IMMUNOLOGY (2002)
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
GJ Wright et al.
IMMUNITY (2000)
Share Paper
